C4 Therapeutics, Inc.
CCCC
$1.54
$0.042.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 244.90M | 255.64M | 264.10M | 258.19M | 253.68M |
| Total Receivables | 3.10M | 10.34M | 1.17M | 13.60M | 11.80M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.76M | 7.25M | 10.78M | 7.80M | 5.71M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 257.77M | 273.23M | 276.04M | 279.59M | 271.19M |
|
|
|||||
| Total Current Assets | 257.77M | 273.23M | 276.04M | 279.59M | 271.19M |
| Net Property, Plant & Equipment | 63.38M | 65.37M | 67.35M | 69.13M | 71.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.10M | 8.70M | 6.06M | 8.67M | 6.17M |
| Total Assets | 349.60M | 376.06M | 381.09M | 398.37M | 376.45M |
|
|
|||||
| Total Accounts Payable | 1.33M | 1.50M | 913.00K | 1.63M | 1.45M |
| Total Accrued Expenses | 17.49M | 13.57M | 8.91M | 10.75M | 15.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.77M | 5.63M | 5.49M | 5.36M | 5.22M |
| Total Finance Division Other Current Liabilities | 20.58M | 22.59M | 38.89M | 37.28M | 20.61M |
| Total Other Current Liabilities | 20.58M | 22.59M | 38.89M | 37.28M | 20.61M |
| Total Current Liabilities | 45.18M | 43.29M | 54.20M | 55.02M | 42.77M |
|
|
|||||
| Total Current Liabilities | 45.18M | 43.29M | 54.20M | 55.02M | 42.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 59.98M | 61.46M | 62.92M | 64.37M | 65.76M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.46M | 28.65M | 16.91M | 20.71M | 21.81M |
| Total Liabilities | 133.62M | 133.40M | 134.04M | 140.09M | 130.34M |
|
|
|||||
| Common Stock & APIC | 849.63M | 841.33M | 821.96M | 815.41M | 774.62M |
| Retained Earnings | -633.70M | -599.13M | -574.46M | -556.74M | -528.38M |
| Treasury Stock & Other | 53.00K | 455.00K | -440.00K | -380.00K | -127.00K |
| Total Common Equity | 215.99M | 242.66M | 247.06M | 258.28M | 246.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 215.99M | 242.66M | 247.06M | 258.28M | 246.11M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 215.99M | 242.66M | 247.06M | 258.28M | 246.11M |
|
|
|||||